Brief: CSL Says CSL Seqirus & Vaccine Industrial Sign Landmark MoU With Ministry Of Health
30/10/2025 08:18
Oct 30 (Reuters) - CSL Ltd CSL.AX: CSL SEQIRUS AND VACCINE INDUSTRIAL COMPANY SIGN LANDMARK MEMORANDUM OF UNDERSTANDING WITH MINISTRY OF HEALTH MOU TO LOCALIZE MANUFACTURING OF CELL-BASED SEASONAL AND PANDEMIC INFLUENZA VACCINES Further company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Csl
See all newsEU Commission opens antitrust probe into Sanofi's flu vaccine campaign (updated)
EU Commission opens antitrust probe into Sanofi's flu vaccine campaign
Analysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
US military requires flu vaccine for some after outbreak in Texas training center
Corrected: BUZZ-Australian healthcare stocks hit a six-week high, acting as a primary hedge on ASX